top of page

Therapeutic Experience

Managed / Directed more than 350 clinical trials Phases I-IV

Project Manager Experience - 26 studies in patient populations

  • Immunology / Inflammation (6 Phase II/III studies)

    • Wound healing

    • Soft tissue inflammation

  • Endocrinology / Metabolism (4 Phase 1b/II studies)

    • Obesity

    • Growth hormone deficiency

    • Acromegaly

    • Pituitary/adrenal disorders

  • Dermatology (4 Phase II/III studies)

    • Atopic dermatitis

    • Burn itch

    • Acne vulgaris

  • Infectious Disease (2 Phase IIa studies)

    • Influenza vaccine

    • Oral warts

  • Oncology (7 Phase I-IV studies)

    • Breast

    • Lung

    • Prostate

    • Melanoma

    • Kidney

  • Pulmonary (2 Phase IIa studies)

    • Asthma (exercise and allergen induced)

  • Genitourinary (1 Phase 1 study)

    • Erectile dysfunction

​

Project / Program Oversight Experience - 79 studies in patient populations

  • Immunology / Inflammation (1 Phase 1b study)

    • Rheumatoid Arthritis​

  • Endocrinology / Metabolism (7 Phase Ib/IIa studies)​

    • Type II Diabetes​

    • Obesity

  • Dermatology (3 Phase Ib/IIa studies)​

    • Atopic dermatitis​

    • Psoriasis

  • Cardiovascular (3 Phase Ib, IV studies)​

    • Hypercholesterolemia​

    • Hear failure

  • Neurology (13 Phase Ib/IIa studies)​

    • Anesthetic​

    • Pain (non-inflammatory)

    • Migraine

    • Alzheimer's Disease

    • Amyotrophic Lateral Sclerosis

    • Parkinson's Disease

  • Psychiatry (8 Phase Ib/II studies)​

    • Schizophrenia​

    • Major Depressive Disorder

    • Generalized Anxiety Disorder

  • Infectious Disease (1 Phase IIa study)​

    • Hepatitis C​

  • Oncology (16 Phase I-III studies)​

    • Ovarian​

    • Sarcomas

    • Gastric

    • Hepatic

    • Adenoid Cystic Carcinoma

    • Solid tumors (various)

    • Melanoma

    • Pancreatic

    • Colorectal

    • Breast

  • Gastroenterology / Hepatology (7 Phase Ib/IIa studies)​

    • Gastroparesis​

    • Inflammatory Bowel Disease

    • Irritable Bowel

    • NASH

  • Pulmonary (9 Phase IIa/II studies)​

    • Tobacco - risk reduction​

    • Idiopathic pulmonary fibrosis

  • Genitourinary (2 Phase IIa, IV)​

    • Chronic Kidney Disease​

    • Hyperphosphatemia

  • Rare Diseases (7 Phase IIa/III)​

    • Mitochondrial Respiratory Chain Disease​

    • Tumor-induced osteomalacia

    • Epidermal Nevus Syndrome

    • X-linked Hypophasphatemic Osteomalacia

    • Gaucher's Disease

  • Ophthalmology (2 Phase II/III studies)​

    • Age-related macular degeneration​

​

Clinical Pharmacology Project Management / Oversight - 245 studies in healthy subjects

  • Single Ascending Dose​​ (SAD)

  • Multiple Ascending Dose (MAD)

  • Human Absorption / Metabolism / Excretion (hAME) - 14C radiolabeled

  • Drug-drug Interaction (DDI)

  • Cardiac safety (including thorough QTc [TQT])

  • Food Effect

  • Gastric pH

  • Renal Impairment

  • Hepatic Impairment

  • Bioequivalence (BE)

  • Bioavailability (BA)

  • Biocompatibility

  • Age and gender

  • Ethnic Bridging

  • PK / PD (clinical pharmacokinetics / pharmacodynamics)

Nearly 30 years organizing, planning and developing global drug development teams. Moving molecules from discovery to approval.

+1 208-840-0119

Email: Steven@NortonClinicalDevelopment.com   

Preston, ID

  • LinkedIn

© 2023 by GoOn Startup. Proudly created with Wix.com

bottom of page